Phase III Study of AK112 for NSCLC Patients

Clinical trial NCT06396065 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06396065
Sponsor: Summit Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Squamous Non-small Cell Lung Cancer

Start date: 2023-05-04
Primary completion: 2025-04-12
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.